Galectin Therapeutics Inc. (GALT) Stock Forecast & Price Prediction 2025, 2030, 2040, and 2050
Find Galectin Therapeutics Inc. (GALT) short-term stock forecasts for 2025 by month and long-term price predictions for 2025 to 2050. View past performance, analyst Buy, Sell or Hold ratings, and the latest GALT stock news and headlines.
1 Month Prediction
$4.92 [249.04%]
3 Month Prediction
$5.19 [268.23%]
6 Month Prediction
$5.32 [277.15%]
1 Year Prediction
$4.95 [251.08%]
3 Year Prediction
$6.21 [340.33%]
5 Year Prediction
$7.59 [438.36%]
About Galectin Therapeutics Inc.
Galectin Therapeutics Inc. is a biotechnology company that develops new therapies for serious diseases, particularly chronic liver and skin diseases and cancer, by targeting galectin proteins.
The company's lead drug candidate, belapectin (GR-MD-02), is a is a carbohydrate-based drug that inhibits the galectin-3, a protein implicated in inflammatory and fibrotic diseases. Also, Belapectin treats non-alcoholic steatohepatitis (NASH) cirrhosis, a severe liver disease with limited treatment options.
The company was founded in 2015 and is headquarted in Norcross, Georgia.
Galectin Therapeutics Inc. (GALT) Historical Performance
IPO Date
Galectin Therapeutics Inc. (NASDAQ:GALT) went public on 23 March, 2012.
Change
Since inception, GALT has decreased by 93.09%. In the last 5 years, GALT has fallen from $1.96 to $1.41, a massive -28.06% decrease since 2020.
Historical Highs and Lows
In the past 5 years, the stock reached a high of $4.42 and a low of $1.13.
52 Week Range
$0.73
$4.27
The current price $1.41 is not near the 52-week extremes, which means that the stock is neither overbought nor underbought.
GALT Stock Price History
Based on GALT stock's historical price data, this table shows how the stock has performed in the last 6 years. Since 2019, the GALT stock has fallen from $1.96 - $3.06 to $1.25 - $1.41, which is down -65.31%. Currently, the stock follows downward trend.
Here, we have calculated stock range of GALT, indicating the highs and lows for each year, the average price based on the daily closing prices each year, and the change% from the average price.
| Year | Stock Price | Avg Price | Change% | Year Change |
|---|---|---|---|---|
| 2020 | $1.96 - $3.06 | $2.55 | -33.49 | 1 Year Change |
| 2021 | $1.96 - $4.42 | $3.03 | -20.97 | 2 Year Change |
| 2022 | $1.13 - $2.26 | $1.59 | -58.53 | 3 Year Change |
| 2023 | $1.16 - $2.1 | $1.74 | -54.62 | 4 Year Change |
| 2024 | $1.29 - $3.51 | $2.43 | -36.62 | 5 Year Change |
| 2025 | $1.25 - $1.41 | $1.33 | -65.31 | 6 Year Change |
GALT Price Performance
6-Month Performance
GALT stock dropped by 48.73% in the last six months.
1-Year Performance
The stock has trended downwards by 41.00% in the past year.
3-Year Performance
In the last 3 years, the stock has plummeted by 12.42%.
5-Year Performance
In the last 5 years, the stock has gone down by 28.06%.
According to Galectin Therapeutics Inc.'s historical data, below graph gives us the exact picture of how the GALT stock has performed year-over-year. Here, Each bar on the graph represents a particular year that illustrates how the stock's price changed from one year to the next.
YoY Performance
In the last five years, the stock has shown positive growth in 1 year and a decline in 4 years.
2020
21.68% ↓
2021
7.59% ↓
2022
45.41% ↓
2023
46.90% ↑
2024
22.29% ↓
NOTE: Green bars indicate that the stock has risen compared to the previous year, while red bars show that the stock has fallen.
Galectin Therapeutics Inc. (GALT) Financials & Stock Analysis
Market Capitalization
Galectin Therapeutics Inc. has a market capitalization of $88.49M, which places GALT in the micro-cap category.
Fundamental Analysis
EPS: $-0.18 (Q3), $-0.74 (1Y)
EPS decreased 10.00% since last quarter, and increased 13.85% since last year.
Net Income: $-11.22 M (Q3), $-41.07 M (1Y)
Net Income decreased 9.30% since last quarter, and increased 5.91% since last year.
Free Cash Flow: $-8.54 M (Q3), $-32.97 M (1Y)
Free Cash Flow increased N/A since last quarter, and increased N/A since last year.
Below, we have listed 12 key indicators for Fundamental analysis for GALT stock. These indicators help you understand Galectin Therapeutics Inc.'s financial health, earnings and growth potential, and make a decision if the stock is a good long-term investment or not.
|
|
Technical Analysis
Here, we have listed 5 key indicators for Technical Analysis for GALT stock. These indicators help investors study past price movements and trading volumes to forecast future price changes, and find the right time when to buy, sell or hold the stock.
| Technical Indicators | Value |
|---|---|
| SMA20 | $1.27 |
| SMA50 | $1.43 |
| SMA200 | $2.34 |
| RSI | 82.76 |
| Beta | 0.82 |
SMA20 < Current Price
This signals GALT stock is in short-term bullish momentum.
SMA50 > Current Price
This signals GALT stock is in mid-term bearish momentum.
SMA200 > Current Price
This signals GALT stock is in long-term bearish momentum.
Sentiment Based on Technical Analysis
Based on 8 technical analysis indicators, the overall sentiment for GALT stock is Bearish. Out of all indicators, 2 indicates bullish signals, 5 signals bearish trends and 2 gives neutral trends. The GALT stock forecast was last updated on 18 February, 2025.
Galectin Therapeutics Inc. (GALT) Stock Price Prediction and Forecast
According to short-term forecast, the stock is expected to rise to $4.72 by the end of 2025, and can reach around $4.39 to $9.22 in 2026. And, the long-term forecast suggests that the stock may further jump to $6.52 - $8.30 in 2028, and $5.37 - $11.01 by 2031. So, the GALT stock shows a strong upward trend in the next several years.
Short-term GALT Stock Price Prediction & Forecast
| Date | Forecasted Price | Change% |
|---|---|---|
| 2025-03 | $4.92 | 248.94% |
| 2025-04 | $6.01 | 326.24% |
| 2025-05 | $5.19 | 268.09% |
| 2025-06 | $4.74 | 236.17% |
| 2025-07 | $5.04 | 257.45% |
| 2025-08 | $5.32 | 277.3% |
| 2025-09 | $5.15 | 265.25% |
| 2025-10 | $5.22 | 270.21% |
| 2025-11 | $5.05 | 258.16% |
| 2025-12 | $4.72 | 234.75% |
In 2025, the GALT stock price is expected to fluctuate between $4.72 and $6.01. According to the monthly forecast, the stock could rise to $4.72 by December 2024. If compared to the GALT's current price, the stock could gain 234.75% by the end of this year.
Long-term GALT Stock Price Prediction & Forecast
| Year | Year Start | Year Mid | Year End | Change% |
|---|---|---|---|---|
| 2026 | $4.39 | $6.53 | $9.22 | 553.9% |
| 2027 | $5.94 | $4.24 | $7.98 | 465.96% |
| 2028 | $6.52 | $10.78 | $8.30 | 488.65% |
| 2029 | $6.93 | $7.56 | $9.07 | 543.26% |
| 2030 | $8.21 | $9.05 | $7.75 | 449.65% |
| 2031 | $5.37 | $9.26 | $11.01 | 680.85% |
| 2032 | $11.05 | $7.45 | $11.65 | 726.24% |
| 2033 | $9.93 | $9.51 | $9.76 | 592.2% |
| 2034 | $8.71 | $11.63 | $13.33 | 845.39% |
| 2035 | $11.53 | $13.26 | $12.97 | 819.86% |
| 2036 | $9.05 | $8.29 | $16.57 | 1075.18% |
| 2037 | $10.67 | $13.05 | $12.13 | 760.28% |
| 2038 | $13.33 | $13.89 | $16.25 | 1052.48% |
| 2039 | $13.59 | $12.32 | $19.28 | 1267.38% |
| 2040 | $14.30 | $17.28 | $16.37 | 1060.99% |
| 2041 | $21.61 | $9.81 | $19.99 | 1317.73% |
| 2042 | $11.74 | $16.71 | $15.90 | 1027.66% |
| 2043 | $17.32 | $19.69 | $22.94 | 1526.95% |
| 2044 | $16.62 | $21.26 | $21.55 | 1428.37% |
| 2045 | $28.00 | $20.00 | $20.17 | 1330.5% |
| 2046 | $18.83 | $21.85 | $24.29 | 1622.7% |
| 2047 | $22.67 | $19.18 | $22.94 | 1526.95% |
| 2048 | $21.57 | $17.38 | $22.90 | 1524.11% |
| 2049 | $23.18 | $24.48 | $17.41 | 1134.75% |
| 2050 | $14.91 | $24.69 | $21.81 | 1446.81% |
| 2051 | $27.49 | $20.00 | $23.09 | 1537.59% |
Galectin Therapeutics Inc. (GALT) Stock Price Prediction & Forecast 2025
At the start of 2025, the GALT stock was at $1.25. Today, it is trading at $1.41, which is 12.80% increase from price at the beginning of the year. By the end of this year, you can expect the stock to reach to $4.72 by December 2025 with a 234.75% change.
Galectin Therapeutics Inc. (GALT) Stock Price Prediction & Forecast 2026 - 2030
In the next five years, there will be a significant appreciation in the GALT stock. During this period, the GALT's price is forecasted to shift from $4.39 to $7.75, which is 76.54% gain.
In 2026, the stock would possibly open at $4.39, escalates to $6.53 by mid-year, and wraps up at $9.22, reflecting a 553.59% increase from today's price. Further moving to 2030, the stock can kick off the year at $8.21, soar to $9.05 by mid-year, and finish at $7.75, which is 450.00% change from current price.
Galectin Therapeutics Inc. (GALT) Stock Price Prediction & Forecast 2031 - 2040
During this period, the stock would move from $5.37 to $16.37, which is up 681.06%
In 2031, we can expect GALT to fluctuate between $5.37 and $11.01, a shift indicating a 681.06% gain by year-end compared to current price. And Until 2040, GALT can likely vary from $14.30 to $16.37. By the end of 2040, the stock could record a 1061.25% rise from today's stock price.
Galectin Therapeutics Inc. (GALT) Stock Price Prediction & Forecast 2041 - 2050
According to long-term forecast, the GALT stock can see an an upturn from $21.61 to $21.81 in this period. In 2041, the stock can experience a low of $9.81 by mid-year, closing the year at $19.99. This results in a 595.61% increase from today.
Moving towards the end of 2050, GALT is projected to open the year at $14.91. The stock may peak to $24.69 during mid-year and finish the year at $21.81. Compared to the stock's current price, this translates to an overall gain of 1446.95% by 2050.
Become a member
Get the latest news right in your inbox. We never spam!
GALT Competitors
| Ticker | Company | Market Cap | Price | 1m Change | Forecast |
|---|---|---|---|---|---|
| SLDB | Solid Biosciences Inc. | - | $5.52 | 73.58% ▲ | $179.37 ▲ |
| ADTX | Aditxt, Inc. | - | $0.07 | -34.58% ▼ | $1328.57 ▲ |
| CRSP | CRISPR Therapeutics AG | - | $49.72 | 19.55% ▲ | $90.65 ▲ |
| MBRX | Moleculin Biotech, Inc. | - | $2.18 | 44.37% ▲ | $336.52 ▲ |
| MNMD | Mind Medicine (MindMed) Inc. | - | $9.89 | 45.66% ▲ | $96.36 ▲ |
Last updated Feb 18 at 1:59 PM
GALT : Buy, Sell Or Hold?
Analyst Ratings
Sorry, No analyst ratings available for this stock.
Expert Analysis
According to GALT short-term and long-term forecast, Galectin Therapeutics Inc. shares are projected to go up by 1446.81%, and reach a value of $21.81 per share by 2050.
As per technical analysis, indicators show a Bearish sentiment, while Fear & Greed Index stands at 42.857142857142854, which signals Fear. Also, GALT has recorded 9/30 green days, which reflects a 40.909090909090914% positivity rate with a price volatility of 0.04%.
Plus, Price-to-Earnings (P/E) ratio of 0 suggests that GALT stock is undervalued. So, Based on GALT prediction and analysis, it may be the best time to sell GALT stock right now.
Disclaimer: Stock predictions, forecasts and price targets provided for "GALT” are solely for informational and educational purposes and should not be treated as investment or financial advice. Always conduct your own research or consider consulting with a financial advisor before making any investment decisions.